SACRIPANTI, GINEVRA
 Distribuzione geografica
Continente #
NA - Nord America 328
EU - Europa 322
AS - Asia 107
AF - Africa 20
OC - Oceania 6
SA - Sud America 2
Totale 785
Nazione #
US - Stati Uniti d'America 319
IT - Italia 166
SE - Svezia 71
CN - Cina 50
DE - Germania 37
SG - Singapore 30
BG - Bulgaria 19
CI - Costa d'Avorio 18
IN - India 9
NL - Olanda 9
VN - Vietnam 9
CA - Canada 8
AU - Australia 6
DK - Danimarca 5
HK - Hong Kong 4
GB - Regno Unito 3
PT - Portogallo 3
UA - Ucraina 3
BR - Brasile 2
CZ - Repubblica Ceca 2
FR - Francia 2
KR - Corea 2
DM - Dominica 1
IR - Iran 1
JP - Giappone 1
NG - Nigeria 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TR - Turchia 1
Totale 785
Città #
Chandler 50
Serra 38
Milan 34
Frankfurt am Main 19
Sofia 19
Abidjan 18
New York 18
Singapore 17
Ashburn 16
Houston 16
Wilmington 16
Beijing 14
Fairfield 14
Pisa 12
Seattle 11
Boardman 10
Florence 10
Princeton 10
Woodbridge 10
Cambridge 9
Santa Clara 9
Bremen 8
Lawrence 8
Rome 8
Medford 7
Dong Ket 6
Hobart 6
Ottawa 6
Pune 6
Ann Arbor 5
Dearborn 4
Des Moines 4
Guiyang 4
Rødovre 4
Baleia 3
Fuzhou 3
Norwalk 3
Redwood City 3
Bracciano 2
Central District 2
Cerro Maggiore 2
Charleston 2
Chengdu 2
Hong Kong 2
Jacksonville 2
Madison 2
Mestrino 2
Nanjing 2
Ogden 2
Oosterhout 2
Pietrasanta 2
Portland 2
San Francisco 2
Shanghai 2
Shenzhen 2
Thrissur 2
Torino 2
Toronto 2
Xian 2
Abano Terme 1
Amsterdam 1
Avezzano 1
Berlin 1
Brno 1
Brooklyn 1
Changsha 1
Chennai 1
Chicago 1
Cumming 1
Dakar 1
Denton 1
Dongguan 1
Falls Church 1
Guangzhou 1
Horia 1
Indiana 1
Istanbul 1
Ivry-sur-Seine 1
Kilburn 1
Kish 1
Lagos 1
Langfang 1
Livorno 1
London 1
Los Angeles 1
Lucca 1
Marsala 1
Mountain View 1
Nanchang 1
Naples 1
Ningbo 1
Norcross 1
Olomouc 1
Quanzhou 1
Roseau 1
San Antonio 1
San Diego 1
Sesto Fiorentino 1
Seveso 1
Shenyang 1
Totale 541
Nome #
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study 139
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection. 127
3,5-diiodo-L-thyronine increases glucose consumption in cardiomyoblasts without affecting the contractile performance in rat heart 105
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway 92
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum. 91
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade 80
Effects of 3,5-diiodo-L-thyronine on the cardiac tissue 71
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. 71
Exogenous 3-Iodothyronamine (T1AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA1) 36
Totale 812
Categoria #
all - tutte 2.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202071 0 0 0 0 4 8 8 16 8 13 12 2
2020/202176 2 5 12 2 7 15 1 10 8 2 1 11
2021/2022101 2 4 0 2 20 14 2 4 8 4 16 25
2022/2023208 31 32 14 16 7 21 0 15 52 1 15 4
2023/2024133 12 14 20 12 16 25 3 5 6 2 10 8
2024/202562 3 16 3 23 17 0 0 0 0 0 0 0
Totale 812